Natco Pharma

Hyderabad, India Founded: 1981 • Age: 45 yrs
APIs and finished dosage forms are developed and manufactured.
Request Access

About Natco Pharma

Natco Pharma is a company based in Hyderabad (India) founded in 1981 by Venkaiah Chowdary Nannapaneni.. The company has 4,960 employees as of March 31, 2024. Natco Pharma has completed 1 acquisition, including Dash Pharmaceuticals. Natco Pharma offers products and services including Generic Drugs and Active Pharmaceutical Ingredients.

  • Headquarter Hyderabad, India
  • Employees 4960 as on 31 Mar, 2024
  • Founders Venkaiah Chowdary Nannapaneni
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Natco Pharma Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $515.77 M (USD)
    10.88
    as on Mar 31, 2024
  • Net Profit
    $220.21 M (USD)
    35.81
    as on Mar 31, 2024
  • EBITDA
    $262.5 M (USD)
    23.45
    as on Mar 31, 2024
  • Latest Funding Round
    $143.25 M (USD), Post-IPO

    Dec 01, 2017

  • Investors
  • Employee Count
    4960

    as on Mar 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Natco Pharma

Natco Pharma is a publicly listed company on the NSE with ticker symbol NATCOPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: NATCOPHARM . Sector: Health technology · India

Products & Services of Natco Pharma

Natco Pharma offers a comprehensive portfolio of products and services, including Generic Drugs and Active Pharmaceutical Ingredients. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Generic versions of oncology drugs are developed and marketed to enhance affordability in domestic and international markets

Active pharmaceutical ingredients are manufactured and supplied from specialized facilities to support formulation needs

People of Natco Pharma
Headcount 1000-5000
Employee Profiles 49
Board Members and Advisors 5
Employee Profiles
People
V.c. Nannapaneni
MD
People
Rajeev Nannapaneni
CEO
People
Chaitanya Jannila
HRBP
People
Aswani Kumar Kancherla
Senior Manager (analytical R&d - Nmr)

Unlock access to complete

Board Members and Advisors
people
Sri D.g Prasad
Independent Director
people
Sri T.v Rao
Independent Director
people
Sri G.s Murthy
Chairman
people
M.u.r Naidu
Independent Director

Unlock access to complete

Funding Insights of Natco Pharma

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $143.2M
  • First Round

    (01 Dec 2011)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2017 Amount Post-IPO - Natco Pharma Valuation

investors

Oct, 2017 Amount Post-IPO - Natco Pharma Valuation

investors

Dec, 2013 Amount Post-IPO - Natco Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Natco Pharma

Natco Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Multiples Alternate Asset Management, CX Partners and Kotak Investment Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment partnerships, entrepreneur support, and profit-focused services in finance.
Founded Year Domain Location
Private equity investments in India are managed by CX Partners.
Founded Year Domain Location
Provider of investment advisory services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Natco Pharma

Natco Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dash Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Advanced spectroscopic and laser instrumentation is developed for industrial applications.
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Natco Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Natco Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Natco Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Natco Pharma

Frequently Asked Questions about Natco Pharma

When was Natco Pharma founded?

Natco Pharma was founded in 1981 and raised its 1st funding round 30 years after it was founded.

Where is Natco Pharma located?

Natco Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Who is the current CEO of Natco Pharma?

Rajeev Nannapaneni is the current CEO of Natco Pharma.

How many employees does Natco Pharma have?

As of Mar 31, 2024, the latest employee count at Natco Pharma is 4,960.

What is the annual revenue of Natco Pharma?

Annual revenue of Natco Pharma is $515.77M as on Mar 31, 2024.

What does Natco Pharma do?

Natco Pharma was founded in 1981 and is headquartered in Hyderabad, India. Operations are focused on the pharmaceutical sector, where active pharmaceutical ingredients and finished dosage forms are developed and manufactured. A pipeline of generic drugs is maintained, alongside a drug discovery research program in oncology. Emphasis is placed on niche therapeutic areas, complex products, contract manufacturing, and marketing of drug formulation services.

What products or services does Natco Pharma offer?

Natco Pharma offers Generic Drugs and Active Pharmaceutical Ingredients.

Is Natco Pharma publicly traded?

Yes, Natco Pharma is publicly traded on NSE under the ticker symbol NATCOPHARM.

How many acquisitions has Natco Pharma made?

Natco Pharma has made 1 acquisition, including Dash Pharmaceuticals.

Who are Natco Pharma's investors?

Natco Pharma has 3 investors. Key investors include Multiples Alternate Asset Management, CX Partners, and Kotak Investment Advisors.

What is Natco Pharma's ticker symbol?

The ticker symbol of Natco Pharma is NATCOPHARM on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available